Back to search
FDAFDA · Food and drugs·Recall number D-1120-2015

Bimix (PHENT;PAP) (N), solution, (10/300) 1 - 30 mg/mL, injectable, 5ml vial, Rx only, compounded by Montana Compounding Pharmacy in Missoula, MT.

Published June 17, 2015 · Recall initiated: May 15, 2015

Summary

FDA records drug Class II recall D-1120-2015, published June 17, 2015 and initiated May 15, 2015. Recalling firm: Montana Compounding Pharmacy; Status: Terminated; Reported quantity: 1/5mL vial; Lot: Lot 04102015:18@15, expiry date: 7/3/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Montana Compounding Pharmacy
Distributor
MT and ND
Lot
Lot 04102015:18@15, expiry date: 7/3/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bimix (PHENT;PAP) (N), solution, (10/300) 1 - 30 mg/mL, injectable, 5ml vial, Rx only, compounded by Montana Compounding Pharmacy in Missoula, MT. recalled?

Yes. FDA published recall D-1120-2015 on June 17, 2015. Reported hazard: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated · Letter